<seo title="Abbvie" metakeywords="abbvie global biopharmaceutical,abbvie financial performance,abbvie developed commercialized,company abbvie abbvie" metadescription="Abbvie is a global biopharmaceutical company that is focused on developing and commercializing innovative therapies to treat serious illnesses."/>
===Introduction to Abbvie===
Abbvie is a global biopharmaceutical company that is focused on developing and commercializing innovative therapies to treat serious illnesses. Abbvie was founded in 2013 as a spin-off of Abbott Laboratories, and is now a publicly traded company on the New York Stock Exchange. Abbvie is headquartered in North Chicago, Illinois, and has operations in more than 170 countries. Abbvie is a leader in the pharmaceutical industry, with a focus on developing treatments for chronic and rare diseases. Abbvie is committed to providing innovative treatments to improve the lives of patients around the world.
===History of Abbvie===
Abbvie was founded in 2013 as a spin-off of Abbott Laboratories. Abbott Laboratories was founded in 1888 and was a leader in the healthcare industry for more than 125 years. In 2013, Abbott Laboratories decided to spin-off its pharmaceutical business into a separate company, Abbvie. Abbvie was created to focus on developing and commercializing innovative therapies to treat serious illnesses. Since its founding, Abbvie has grown to become a leader in the pharmaceutical industry.
===Abbvie’s Financial Performance===
Abbvie has had strong [[Financial Performance|financial performance]] since its founding in 2013. In 2020, Abbvie reported total revenue of $37.6 billion, an increase of 8.3% from the previous year. Abbvie’s [[Net Income|net income]] for 2020 was $7.3 billion, an increase of 11.3% from the previous year. Abbvie’s strong financial performance is driven by its focus on developing and commercializing innovative therapies to treat serious illnesses.
===Abbvie’s Products and Services===
Abbvie is focused on developing and commercializing innovative therapies to treat serious illnesses. Abbvie’s products and services include treatments for chronic and rare diseases, such as cancer, HIV/AIDS, hepatitis , and multiple sclerosis. Abbvie also offers a range of other products and services, such as diagnostics, vaccines, and medical devices.
===Abbvie’s Impact on the Pharmaceutical Industry===
Abbvie has had a significant impact on the pharmaceutical industry since its founding in 2013. Abbvie has developed and commercialized innovative therapies to treat serious illnesses, which has improved the lives of patients around the world. Abbvie has also invested heavily in research and development, which has led to the development of new treatments and therapies.
===Conclusion===
Abbvie is a global biopharmaceutical company that is focused on developing and commercializing innovative therapies to treat serious illnesses. Abbvie has had strong financial performance since its founding in 2013, and has had a significant impact on the pharmaceutical industry. Abbvie is committed to providing innovative treatments to improve the lives of patients around the world